AnasAl-JanadiMD
Oncology • Grand Rapids, MIHematologic Oncology
Vice President/Dept. Chief, Cancer Health Service Line, Spectrum Health. Associate Professor, Hematology/Oncology, Michigan State University
Dr. Al-Janadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
145 Michigan St NE
5120
Grand Rapids, MI 49503Phone+1 616-486-6180
Education & Training
Henry Ford Health/Henry Ford HospitalFellowship, Hematology and Medical Oncology, 1998 - 2001
St Barnabas HospitalResidency, Internal Medicine, 1995 - 1998
Damascus University Faculty of MedicineClass of 1991
Certifications & Licensure
MI State Medical License 1998 - 2026
NV State Medical License 2002 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
Publications & Presentations
PubMed
- A Short Course of Standard Velcade/Dexamethasone Followed by Unlimited Weekly Maintenance Therapy Is an Effective Treatment in Relapsed/Refractory Multiple Myeloma.Harini Acharya Gangur, Harsha Trivedi, UshaSree Chamarthy, Anas Al-Janadi, Gordan Srkalovic
Cancers. 2024-11-12 - 2 citationsCholesterol crystals induce mechanical trauma, inflammation, and neo-vascularization in solid cancers as in atherosclerosis.George S Abela, Venkat R Katkoori, Dorothy R Pathak, Harvey L Bumpers, Monika Leja
American Heart Journal Plus. 2023-11-01 - Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST study.Ellen Ritchie, Anas Al-Janadi, Craig Kessler, Robyn Scherber, Tricia Kalafut
Leukemia & Lymphoma. 2022-12-01
Press Mentions
Doctor: Less Alcohol, More Exercise Can Lower Risk of Breast CancerOctober 24th, 2024- Real-World Survival Inferior to Clinical Trials for Certain Metastatic Breast Cancer TreatmentsJuly 13th, 2021
Professional Memberships
- Member
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
